MassHealth Pharmacy Initiatives and Clinical Information
Concomitant Opioid Benzodiazepine Initiative See Table 69
Please see the links below for a description of the Concomitant Opioid Benzodiazepine Initiative (COBI), including a medication list and frequently asked questions. The link to Table 69 above can be used for more information on PA requirements and evaluation criteria.
Concomitant Opioid Benzodiazepine Initiative |
Pediatric Behavioral Health Medication Initiative See Table 71
Please see the links below for a description of the Pediatric Behavioral Health Medication Initiative (PBHMI), including a medication list and situations that require prior authorization (PA) for members < 18 years of age. The link to Table 71 above can be used for more information on PA requirements and evaluation criteria.
Pediatric Behavioral Health Medication Initiative |
Please see the following link to find out more information about the Pediatric Behavioral Health Medication Initiative (e.g., Letter to Prescribers).
Opioid and Pain Initiative See Table 8
Please see the following link to find more Opioids and Controlled Substances Information (e.g., Letter to Prescribers).
https://www.mass.gov/lists/opioids-and-controlled-substances-information
Second-Generation (Atypical) Antipsychotic Initiative See Table 24
Please see the following link to find out more information about second-generation (atypical) antipsychotics (e.g., Letter to Prescribers).
https://www.mass.gov/lists/second-generation-antipsychotics-also-known-as-atypical-antipsychotics
Hospital Outpatient Prior Authorization Initiative
Please see the following links to find out more information about Provider Transmittal Letters and Subchapter 6.
https://www.mass.gov/lists/all-provider-transmittal-letters
https://www.mass.gov/doc/physician-phy-subchapter-6/download